Skip to NavigationSkip to content

Medical device user fees to increase 68% for 2018 to 2022

Published on 25/08/16 at 08:48am

The Food and Drug Administration has reached an agreement with the medical device industry and laboratory community on proposed recommendations for the fourth reauthorisation of a medical device user fee programme. Under this new agreement, the FDA is authorised to collect $999.5 million in user fees plus inflation over five years, a 68% increase from the $595 million in 2012.

The deal also sets lower time goals for reviewing 510,000 premarket notifications and premarket approval applications and would require the agency to provide feedback to companies at least five days before presubmission meetings are held. It additionally requires two independent analyses of the FDA’s handling of review process in order to increase accountability. Furthermore, the FDA is expected to bundle all of its user fee programmes into a single legislative package.

The Advanced Medical Technology Association, Medical Device Manufacturers Association and Medical Imagin & Technology Alliance have all voiced their support of the deal, claiming it will enable the FDA to hire additional reviewers and improve its IT and infrastructure.

According to Jeffrey Shuren, director of the Center for Devices and Radiological Health, the agreement “reflects the efforts the FDA has made to meet or exceed its performance goals and to help speed patient access to safe and effective medical devices.”

Final recommendations on the fees are due to be reviewed by congress in January.

Matt Fellows

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches